You can moderate the speed of weight loss
Other common gastrointestinal adverse effects include constipation, vomiting (59% in diabetes trials, higher in obesity trials), diarrhea (1316%), decreased appetite (59%), and abdominal discomfort
However, this shift in energy processing means clinical oversight is non-negotiable
The FDA labeling for tirzepatide does include warnings about severe gastrointestinal adverse reactions, as well as risks of dehydration, acute kidney injury, and acute gallbladder disease
Is it contaminated
Available data are insufficient to inform recommendations to mitigate the risk of pulmonary aspiration during general anesthesia or deep sedation in patients taking ZEPBOUND, including whether modifying preoperative fasting recommendations or temporarily discontinuing ZEPBOUND could reduce the incidence of retained gastric contents